Hepatic Ischemia-Reperfusion Increases Vascular Endothelial Growth Factor and Cancer Growth in Rats

Journal of Surgical Research

Volumn 148, Issue 2, 2008, Pages 158-163

  Tamagawa, Koji ^a   Horiuchi, Tetsuya ^a   Uchinami, Masaru ^a   Doi, Koji ^a   Yoshida, Makoto ^a   Nakamura, Tomoaki ^a   Sasaki, Hisashi ^a   Taniguchi, Masanobu ^a   Tanaka, Kuniyoshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

flk 1 KDR; flt 1; hepatic ischemia and reperfusion; hypoxia; liver metastasis; vascular endothelial growth factor

Indexed keywords

ASPARTATE AMINOTRANSFERASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; LIVER ISCHEMIA; LIVER METASTASIS; MALE; MICROMETASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPERFUSION;

ADENOCARCINOMA; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER; LIVER NEOPLASMS; MALE; RATS; RATS, INBRED F344; REPERFUSION INJURY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 46249094936     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.12.787     Document Type: Article

References (23)

1. Horiuchi T., Muraoka R., Tabo T., et al. Optimal cycles of hepatic ischemia and reperfusion for intermittent pedicle clamping during liver surgery. Arch. Surg. 130 (1995) 745
2. Uchinami M., Muraoka R., Horiuchi T., et al. Effect of intermittent hepatic pedicle clamping on free radical generation in the rat liver. Surgery 124 (1998) 49
3. Kimura N., Muraoka R., Horiuchi T., et al. Intermittent hepatic pedicle clamping reduces liver and lung damage. J Surg Res 78 (1998) 11
4. Doi K., Horiuchi T., Uchinami M., et al. Hepatic ischemia-reperfusion promotes liver metastasis of colon cancer. J Surg Res 105 (2002) 243
5. Yoshida M., Horiuchi T., Uchinami M., et al. Intermittent hepatic-reperfusion minimizes liver metastasis in rats. J Surg Res 111 (2003) 255
6. Boros P., Tarcsafalvi A., Wang L., et al. Intrahepatic expression and release of vascular endothelial growth factor following orthotopic liver transplantation in the rat. Transplantation 72 (2001) 805
7. Tsurui Y., Sho M., Kuzumoto Y., et al. Dual role of vascular endothelial growth factor in hepatic ischemia-reperfusion injury. Transplantation 79 (2005) 1110
8. Zhang H., Wu J., Meng L., et al. Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells. World J Gastroenterol 8 (2002) 994
9. Graeven U., Fiedler W., Karpinski S., et al. Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR. J Cancer Res Clin Oncol 125 (1999) 621
10. Itakura J., Ishiwata T., Shen B., et al. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer. Int J Cancer 85 (2000) 27
11. Inoue Y., Kashima Y., Aizawa K., et al. A new rat colon cancer cell line metastasizes spontaneously biologic characteristics and chemotherapeutic response. Jpn J Cancer 82 (1991) 90
12. Picardo A., Karpoff H.M., Ng B., et al. Partial hepatectomy accelerates local tumor growth: Potential roles of local cytokine activation. Surgery 124 (1998) 57
13. Loizidou M.C., Lawrance R.J., Holt S., et al. Facilitation by partial hepatectomy of tumor growth within the rat liver following intraportal injection of syngeneic tumor cells. Clin Exp Metastasis 9 (1991) 335
14. Pringle J.H. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 48 (1908) 541
15. Colletti L.M., Kunkel S.L., Walz A., et al. The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology 23 (1996) 506
16. Grunstein J., Roberts W.G., Mathieu-Costello O., et al. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. Cancer Res 59 (1999) 1592
17. Zhao J., Hu J., Cai J., et al. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma. Chin Med J (Engl) 116 (2003) 772
18. Masood R., Cai J., Zheng T., et al. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 98 (2001) 1904
19. Masood R., Cai J., Zheng T., et al. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci USA 94 (1997) 979
20. Mook O.R., Van Marle J., Vreeling-Sindelarova H., et al. Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver. Hepatology 38 (2003) 295
21. Belgore F.M., Blann A.D., and Lip G.Y. sFlt-1, a potential antagonist for exogenous VEGF. Circulation 102 (2000) E108
22. Goldman C.K., Kendall R.L., Cabrera G., et al. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc Natl Acad Sci USA 95 (1998) 879
23. Lu D., Jimenez X., Zhang H., et al. Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy. Int J Cancer 97 (2002) 393